ClinVar Miner

Submissions for variant NM_004004.6(GJB2):c.355G>A (p.Glu119Lys)

gnomAD frequency: 0.00010  dbSNP: rs150529554
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000336897 SCV000383009 likely benign Autosomal dominant nonsyndromic hearing loss 3A 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Illumina Laboratory Services, Illumina RCV000407574 SCV000383010 likely benign Ichthyosis, hystrix-like, with hearing loss 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Illumina Laboratory Services, Illumina RCV000278504 SCV000383011 likely benign Autosomal recessive nonsyndromic hearing loss 1A 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000757332 SCV000885516 uncertain significance not specified 2018-07-01 criteria provided, single submitter clinical testing The c.355G>A; p.Glu119Lys variant (rs150529554) was previously identified in patients with sensorineural hearing loss, but its pathogenicity could not be ascertained and an accompanying pathogenic GJB2 variant could not be identified (Jaradat 2016, Putcha 2007, Wu 2002). It is reported as likely benign in ClinVar (Variation ID: 188488) and is observed in the general population at an overall frequency of 0.009% (25/275896 alleles) in the Genome Aggregation Database. The glutamate at residue 119 is moderately conserved, but computational algorithms (PolyPhen-2, SIFT) predict that this variant is tolerated. Due to limited information regarding this variant, its clinical significance cannot be determined with certainty. References: Jaradat S et al. Molecular analysis of the GJB2 gene in Iraqi patients with sensorineural non-syndromic hearing loss. J Med J. J Med J 2016;50 (3):145- 155. Putcha G et al. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007;9(7):413-26. Wu B et al. Effectiveness of sequencing connexin 26 (GJB2) in cases of familial or sporadic childhood deafness referred for molecular diagnostic testing. Genet Med. 2002;4(4):279-88.
Athena Diagnostics Inc RCV001288924 SCV001476376 uncertain significance not provided 2020-03-31 criteria provided, single submitter clinical testing
GeneDx RCV001288924 SCV001771217 uncertain significance not provided 2023-01-24 criteria provided, single submitter clinical testing Observed as heterozygous with no other GJB2 variants in patients with hearing loss in published literature (Wu et al., 2002; Azaiez et al., 2004; Santos et al., 2005); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 15365987, 12172394, 27153395, 25388846, 25087612, 15656949, 17666888)
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital RCV000678880 SCV000805073 uncertain significance Hearing loss 2017-04-18 no assertion criteria provided clinical testing
Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals RCV001175238 SCV001338804 uncertain significance Sensorineural hearing loss disorder 2019-01-10 no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV001288924 SCV001809130 uncertain significance not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001288924 SCV001953120 uncertain significance not provided no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001288924 SCV001978704 uncertain significance not provided no assertion criteria provided clinical testing
Natera, Inc. RCV000278504 SCV002086050 uncertain significance Autosomal recessive nonsyndromic hearing loss 1A 2020-09-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.